Antibody Mediated Regulation of Humoral Immunity

Chapter

Abstract

Antibodies can regulate the antibody response against the antigen they bind to. This phenomenon is called antibody feedback regulation and can be both positive and negative. Passively administered erythrocyte-specific IgG antibodies can completely prevent an antibody response against erythrocytes. This is used clinically in Rhesus prophylaxis. IgM can enhance the antibody response to large antigens and this effect is dependent on the ability of IgM to activate complement. Enhancement by IgG3 is also dependent on complement whereas IgG1, IgG2a, and IgG2b enhance antibody responses to protein antigens via IgG Fc receptors. Finally, IgE is a potent enhancer of both antibody and CD4 T cells responses and this effect is mediated by the low-affinity receptor for IgE, CD23.

Keywords

Rhesus prophylaxis Feedback regulation CD23 IgM IgE Complement receptor CD21 Fc receptors 

References

  1. Abdelmoula M, Spertini F, Shibata T, Gyotoku Y, Luzuy S, Lambert PH et al (1989) IgG3 is the major source of cryoglobulins in mice. J Immunol 143:526–532PubMedGoogle Scholar
  2. Ahearn JM, Fischer MB, Croix D, Goerg S, Ma M, Xia J et al (1996) Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4:251–262PubMedGoogle Scholar
  3. Amigorena S, Bonnerot C, Drake JR, Choquet D, Hunziker W, Guillet J-G et al (1992) Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256:1808–1812PubMedGoogle Scholar
  4. Applequist SE, Dahlström J, Jiang N, Molina H, Heyman B (2000) Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J Immunol 165:2398–2403PubMedGoogle Scholar
  5. Aubry J-P, Pochon S, Graber P, Jansen KU, Bonnefoy J-Y (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358:505–507PubMedGoogle Scholar
  6. Barnes N, Gavin AL, Tan PS, Mottram P, Koentgen F, Hogarth PM (2002) FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16(3):379–389PubMedGoogle Scholar
  7. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192:271–280PubMedGoogle Scholar
  8. Beliard R (2006) Monoclonal anti-D antibodies to prevent alloimmunization: lessons from clinical trials. Transfus Clin Biol 13(1–2):58–64PubMedGoogle Scholar
  9. Bheekha Escura R, Wasserbauer E, Hammerschmid F, Pearce A, Kidd P, Mudde GC (1995) Regulation and targeting of T-cell immune responses by IgE and IgG antibodies. Immunology 86:343–350PubMedGoogle Scholar
  10. Blank U, Launay P, Benhamou M, Monteiro RC (2009) Inhibitory ITAMs as novel regulators of immunity. Immunol Rev 232(1):59–71PubMedGoogle Scholar
  11. Böttger EC, Hoffmann T, Hadding U, Bitter-Suermann D (1985) Influence of genetically inherited complement deficiencies on humoral immune response in guinea pigs. J Immunol 135:4100–4107PubMedGoogle Scholar
  12. Bowman JM (1988) The prevention of Rh immunization. Transfus Med Rev 2:129–150PubMedGoogle Scholar
  13. Brinc D, Lazarus AH (2009) Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematology Am Soc Hematol Educ Program 185–191Google Scholar
  14. Brinc D, Le-Tien H, Crow AR, Freedman J, Lazarus AH (2007) IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn? Br J Haematol 139(2):275–279PubMedGoogle Scholar
  15. Brinc D, Le-Tien H, Crow AR, Siragam V, Freedman J, Lazarus AH (2008a) Transfusion of IgG-­opsonized foreign red blood cells mediates reduction of antigen-specific B cell priming in a murine model. J Immunol 181(2):948–953, July 15PubMedGoogle Scholar
  16. Brinc D, Le-Tien H, Crow AR, Siragam V, Freedman J, Lazarus AH (2008b) Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn? Immunology 124(1):141–146PubMedGoogle Scholar
  17. Brockman MA, Verschoor A, Zhu J, Carroll MC, Knipe DM (2006) Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J Virol 80(14):7111–7117PubMedGoogle Scholar
  18. Brody NI, Walker JG, Siskind GW (1967) Studies on the control of antibody synthesis. Interaction of antigenic competition and suppression of antibody formation by passive antibody on the immune response. J Exp Med 126:81–91PubMedGoogle Scholar
  19. Brüggemann M, Rajewsky K (1982) Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal anti-hapten antibodies of various isotypes. Cell Immunol 71:365–373PubMedGoogle Scholar
  20. Bystryn J-C, Graf MW, Uhr JW (1970) Regulation of antibody formation by serum antibody. II. Removal of specific antibody by means of exchange transfusion. J Exp Med 132:1279–1287PubMedGoogle Scholar
  21. Carlsson F, Hjelm F, Conrad DH, Heyman B (2007) IgE enhances specific antibody and T cell responses in mice overexpressing CD23. Scand J Immunol 66:261–270PubMedGoogle Scholar
  22. Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105–107PubMedGoogle Scholar
  23. Carter RH, Spycher MO, Ng YC, Hoffmann R, Fearon DT (1988) Synergistic interaction between complement receptor type 2 and membrane IgM on B-lymphocytes. J Immunol 141:457–463PubMedGoogle Scholar
  24. Cerottini JC, McConahey PJ, Dixon FJ (1969) The immunosuppressive effect of passively administered antibody IgG fragments. J Immunol 102:1008–1015PubMedGoogle Scholar
  25. Chan PL, StC Sinclair NR (1973) Regulation of the immune response. VI. Inability of F(ab’)2 antibody to terminate established immune responses and its ability to interfere with IgG antibody-­mediated immunosuppression. Immunology 24:289–310PubMedGoogle Scholar
  26. Cherukuri A, Cheng PC, Sohn HW, Pierce SK (2001) The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity 14(2):169–179PubMedGoogle Scholar
  27. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG (2008) Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9(1):54–62PubMedGoogle Scholar
  28. Clarke CA, Donohoe WTA, Woodrow JC, Finn R, Krevans JR, Kulke W et al (1963) Further experimental studies on the prevention of Rh haemolytic disease. Br Med J 1:979–984PubMedGoogle Scholar
  29. Conrad DH (1990) FcεRII/CD23: the low affinity receptor for IgE. Annu Rev Immunol 8:623–645PubMedGoogle Scholar
  30. Cooper LJ, Schimenti JC, Glass DD, Greenspan NS (1991) H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate. J Immunol 146(8):2659–2663PubMedGoogle Scholar
  31. Coulie P, Van Snick J (1985) Enhancement of IgG anti-carrier responses by IgG2-anti-hapten antibodies in mice. Eur J Immunol 15:793–798PubMedGoogle Scholar
  32. Croix DA, Ahearn JM, Rosengard AM, Han S, Kelsoe G, Ma M et al (1996) Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J Exp Med 183:1857–1864PubMedGoogle Scholar
  33. Cutler AJ, Botto M, van Essen D, Rivi R, Davies KA, Gray D et al (1998) T cell-dependent immune response in C1q-deficient mice: defective interferon γ production by antigen-specific T cells. J Exp Med 187:1789–1797PubMedGoogle Scholar
  34. Czajkowsky DM, Shao Z (2009) The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc Natl Acad Sci USA 106(35):14960–14965PubMedGoogle Scholar
  35. Daeron M, Lesourne R (2006) Negative signaling in Fc receptor complexes. Adv Immunol 89:39–86PubMedGoogle Scholar
  36. Davies KA, Erlendsson K, Beynon HLC, Peters AM, Steinsson K, Valdimarsson H et al (1993) Splenic uptake of immune complexes in man is complement-dependent. J Immunol 151:3866–3873PubMedGoogle Scholar
  37. de Jong JM, Schuurhuis DH, Ioan-Facsinay A, Welling MM, Camps MG, van der Voort EI et al (2006) Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. Immunology 119(4):499–506PubMedGoogle Scholar
  38. Dennert G (1971) The mechanism of antibody-induced stimulation and inhibition of the immune response. J Immunol 106:951–955PubMedGoogle Scholar
  39. Dennert G (1973) Effects of IgM on the in vivo and in vitro immune response. Proc Soc Exp Biol Med 143:889–893PubMedGoogle Scholar
  40. Dennert G, Pohlit H, Rajewsky K (1971) Co-operative antibody: a concentrating device. In: Mäkelä O, Cross A, Kosunen TU (eds) Cell interactions and receptor antibodies in immune responses. Academic, London, pp 3–7Google Scholar
  41. Diaz de Ståhl T, Heyman B (2001) IgG2a-mediated enhancement of antibody responses is dependent of FcRγ+ bone marrow-derived cells. Scand J Immunol 54:1–7Google Scholar
  42. Diaz de Ståhl T, Dahlström J, Carroll MC, Heyman B (2003) A role for complement in feedback-­enhancement of antibody responses by IgG3. J Exp Med 197:1183–1190PubMedGoogle Scholar
  43. Dresser DW (1990) Feedback by early and late primary antisera on the primary and secondary adoptive immune responses of mice to burro erythrocytes. Cell Immunol 127:405–419PubMedGoogle Scholar
  44. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95(17):10089–10093PubMedGoogle Scholar
  45. Enriques-Rincon F, Klaus GGB (1984) Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens. Immunology 52:129–136Google Scholar
  46. Enriquez-Rincon F, Klaus GGB (1984) Follicular trapping of hapten-erythrocyte-antibody complexes in mouse spleen. Immunology 52:107–116PubMedGoogle Scholar
  47. Fang Y, Xu C, Fu Y-X, Holers VM, Molina H (1998) Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J Immunol 160:5273–5279PubMedGoogle Scholar
  48. Ferguson AR, Youd ME, Corley RB (2004) Marginal zone B cells transport and deposit IgM-­containing immune complexes onto follicular dendritic cells. Int Immunol 16(10):1411–1422PubMedGoogle Scholar
  49. Fischer MB, Ma M, Goerg S, Zhou X, Xia J, Finco O et al (1996) Regulation of the B cell response to T-dependent Ags by classical pathway complement. J Immunol 157:549–556PubMedGoogle Scholar
  50. Freedman J, Massey A, Chaplin H, Monroe MC (1980) Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies. Br J Haematol 45(2):309–318PubMedGoogle Scholar
  51. Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Yoshida K et al (1994) The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 91:6835–6839PubMedGoogle Scholar
  52. Gavin AL, Barnes N, Dijstelbloem HM, Hogarth PM (1998) Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J Immunol 160:20–23PubMedGoogle Scholar
  53. Getahun A, Heyman B (2009) Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol 70(3):277–287PubMedGoogle Scholar
  54. Getahun A, Dahlström J, Wernersson S, Heyman B (2004) IgG2a-mediated enhancement of Ab- and T-cell responses and its relation to inhibitory and activating FcγRs. J Immunol 172:5269–5276PubMedGoogle Scholar
  55. Getahun A, Hjelm F, Heyman B (2005) IgE enhances antibody and T cell responses in vivo via CD23+ B Cells. J Immunol 175(3):1473–1482PubMedGoogle Scholar
  56. Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol 8(3):205–217PubMedGoogle Scholar
  57. Greenbury CL, Moore DH (1968) Non-specific antibody-induced suppression of the immune response. Nature 219:526–527PubMedGoogle Scholar
  58. Greenspan NS, Cooper LJN (1992) Intermolecular cooperativity: a clue to why mice have IgG3? Immunol Today 13:164–168PubMedGoogle Scholar
  59. Grundbacher FJ (1992) Behring’s discovery of diphtheria and tetanus antitoxins. Immunol Today 13(5):188–190PubMedGoogle Scholar
  60. Gustavsson S, Hjulström S, Liu T, Heyman B (1994) CD23/IgE-mediated regulation of the specific antibody response in vivo. J Immunol 152:4793–4800PubMedGoogle Scholar
  61. Gustavsson S, Wernersson S, Heyman B (2000) Restoration of the antibody response to IgE/antigen complexes in CD23-deficient mice by CD23+ spleen or bone marrow cells. J Immunol 164:3990–3995PubMedGoogle Scholar
  62. Hamano Y, Arase H, Saisho H, Saito T (2000) Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J Immunol 164(12):6113–6119PubMedGoogle Scholar
  63. Harte PG, Cooke A, Playfair JHL (1983) Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature 302:256–258PubMedGoogle Scholar
  64. Henningsson F, Ding Z, Dahlin JS, Linkevicius M, Carlsson F, Grönvik KO et al (2011) ­IgE-­mediated enhancement of CD4 T cell responses in mice requires antigen presentation by CD11c cells and not by B cells. PLoS One 6(7):e21760PubMedGoogle Scholar
  65. Henry C, Jerne N (1968) Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J Exp Med 128:133–152PubMedGoogle Scholar
  66. Heyman B (1999) Antibody feedback suppression: towards a unifying concept? Immunol Lett 68:41–45PubMedGoogle Scholar
  67. Heyman B (2000) Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 18:709–737PubMedGoogle Scholar
  68. Heyman B (2003) Feedback regulation by IgG antibodies. Immunol Lett 88:157–161PubMedGoogle Scholar
  69. Heyman B, Wigzell H (1984) Immunoregulation by monoclonal sheep erythrocyte specific IgG antibodies. Suppression is correlated to level of antigen binding and not to isotype. J Immunol 132:1136–1143PubMedGoogle Scholar
  70. Heyman B, Wigzell H (1985) IgM enhances and IgG suppresses immunological memory in mice. Scand J Immunol 21:255–266PubMedGoogle Scholar
  71. Heyman B, Andrighetto S, Wigzell H (1982) Antigen dependent IgM-mediated enhancement of the sheep erythrocyte response in mice. Evidence for induction of B cells with specificities other than that of the injected antibodies. J Exp Med 155:994–1009PubMedGoogle Scholar
  72. Heyman B, Hobbs M, Weigle WO (1985) IgM-mediated enhancement of in vivo anti-sheep erythrocyte antibody responses: isotype analysis of the enhanced responses. Cell Immunol 92:134–141PubMedGoogle Scholar
  73. Heyman B, Wiersma E, Nose M (1988a) Complement activation is not required for IgG-mediated suppression of the antibody response. Eur J Immunol 18:1739–1743PubMedGoogle Scholar
  74. Heyman B, Pilström L, Shulman MJ (1988b) Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med 167:1999–2004PubMedGoogle Scholar
  75. Heyman B, Liu T, Gustavsson S (1993) In vivo enhancement of the specific antibody response via the low affinity receptor for IgE. Eur J Immunol 23:1739–1742PubMedGoogle Scholar
  76. Heyman B, Dahlström J, Diaz de Ståhl T, Getahun A, Wernersson S, Karlsson MCI (2001) No evidence for a role of FcγRIIB in suppression of in vivo antibody responses to erythrocytes by passively administered IgG. Scand J Immunol 53:331–334PubMedGoogle Scholar
  77. Hjelm F, Carlsson F, Verbeek S, Heyman B (2005) IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. Scand J Immunol 62(5):453–461PubMedGoogle Scholar
  78. Hjelm F, Carlsson F, Getahun A, Heyman B (2006) Antibody-mediated regulation of the immune response. Scand J Immunol 64(3):177–184PubMedGoogle Scholar
  79. Hjelm F, Karlsson MCI, Heyman B (2008) A novel B-cell mediated transport of IgE-immune complexes to the follicle of the spleen. J Immunol 180:6604–6610PubMedGoogle Scholar
  80. Hjulström S, Landin A, Jansson L, Holmdahl R, Heyman B (1995) No role of interleukin-4 in CD23/IgE-mediated enhancement of the murine antibody response in vivo. Eur J Immunol 25:1469–1472PubMedGoogle Scholar
  81. Jackson CG, Ochs HD, Wedgwood RJ (1979) Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N Engl J Med 300:1124–1129PubMedGoogle Scholar
  82. Junghans RP, Anderson CL (1996) The protection receptor for IgG catabolism is the beta-2-microglobulin-­containing neonatal intestinal transport receptor. Proc Natl Acad Sci USA 93:5512–5516PubMedGoogle Scholar
  83. Karlsson MCI, Wernersson S, Diaz de Ståhl T, Gustavsson S, Heyman B (1999) Efficient IgG-­mediated suppression of primary antibody responses in Fc-gamma receptor-deficient mice. Proc Natl Acad Sci USA 96:2244–2249PubMedGoogle Scholar
  84. Karlsson MCI, Getahun A, Heyman B (2001) FcγRIIB in IgG-mediated suppression of antibody responses: different impact in vivo and in vitro. J Immunol 167:5558–5564PubMedGoogle Scholar
  85. Kehry MR, Yamashita LC (1989) Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc Natl Acad Sci USA 86:7556–7560PubMedGoogle Scholar
  86. Klaus GGB (1978) The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes. Immunology 34:643–652PubMedGoogle Scholar
  87. Klaus GGB (1979) Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen-antibody complexes. Immunology 37:345–351PubMedGoogle Scholar
  88. Klaus GGB, Humphrey JH (1977) The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology 33:31PubMedGoogle Scholar
  89. Krieger N, Pesce A, Michael JG (1983) Immunoregulation of the anti-bovine serum albumin response by polyclonal and monoclonal antibodies. Cell Immunol 80:279–287PubMedGoogle Scholar
  90. Kumpel BM, Elson CJ (2001) Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution? Trends Immunol 22:26–31PubMedGoogle Scholar
  91. Kuo TT, Baker K, Yoshida M, Qiao SW, Aveson VG, Lencer WI et al (2010) Neonatal Fc receptor: from immunity to therapeutics. J Clin Immunol 30(6):777–789PubMedGoogle Scholar
  92. Kurtz CB, O'Toole E, Christensen SM, Weis JH (1990) The murine complement receptor gene family IV: alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J Immunol 144:3581–3591PubMedGoogle Scholar
  93. Lehner P, Hutchings P, Lydyard PM, Cooke A (1983) Regulation of the immune response by antibody II. IgM-mediated enhancement: dependency on antigen dose, T-cell requirement and lack of evidence for an idiotype-related mechanism. Immunology 50:503–509PubMedGoogle Scholar
  94. Link A, Zabel F, Schnetzler Y, Titz A, Brombacher F, Bachmann MF (2012) Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J Immunol 188:3724–3733Google Scholar
  95. Mancardi DA, Iannascoli B, Hoos S, England P, Daeron M, Bruhns P (2008) FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-­induced lung inflammation. J Clin Invest 118(11):3738–3750PubMedGoogle Scholar
  96. Mattsson J, Yrlid U, Stensson A, Schon K, Karlsson MC, Ravetch JV et al (2011) Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant. J Immunol 187(7):3641–3652PubMedGoogle Scholar
  97. Molina H, Kinoshita T, Inoue K, Carel J-C, Holers VM (1990) A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse complement receptors 1 and 2. J Immunol 145:2974–2983PubMedGoogle Scholar
  98. Möller G (1985) Antibody-mediated suppression of the immune response is determinant specific. Eur J Immunol 15:409–412PubMedGoogle Scholar
  99. Möller G, Wigzell H (1965) Antibody synthesis at the cellular level. Antibody-induced suppression of 19S and 7S antibody responses. J Exp Med 121:969–989PubMedGoogle Scholar
  100. Mudde GC, Hansel TT, van Reijsen FC, Osterhoff BF, Bruijnzeel-Koomen CAFM (1990) IgE: an immunoglobulin specialized in antigen capture? Immunol Today 11:440–443PubMedGoogle Scholar
  101. Murphy KM, Heimberger AB, Loh DY (1990) Induction by antigen of intrathymic apoptosis of CD4 + CD8 + TCRlo thymocytes in vivo. Science 250:1720–1723PubMedGoogle Scholar
  102. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV (1994) A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 368:70–73PubMedGoogle Scholar
  103. Na D, Kim D, Lee D (2006) Mathematical modeling of humoral immune response suppression by passively administered antibodies in mice. J Theor Biol 241(4):830–851PubMedGoogle Scholar
  104. Nicholas R StC. Sinclair (1969) Regulation of the immune response. I. Reduction in ability of specific antibody to inhibit longlasting IgG immunological priming after removal of the Fc fragment. J Exp Med 129:1183–1201PubMedGoogle Scholar
  105. Nie X, Basu S, Cerny J (1997) Immunization with immune complex alters the repertoire of antigen-­reactive B cells in the germinal centers. Eur J Immunol 27(12):3517–3525PubMedGoogle Scholar
  106. Nimmerjahn F, Ravetch JV (2005) Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310(5753):1510–1512, December 2PubMedGoogle Scholar
  107. Nimmerjahn F, Ravetch JV (2006) Fcgamma receptors: old friends and new family members. Immunity 24(1):19–28PubMedGoogle Scholar
  108. Nimmerjahn F, Ravetch JV (2010) Antibody-mediated modulation of immune responses. Immunol Rev 236:265–275PubMedGoogle Scholar
  109. O’Neil KM, Ochs SR, Heller SR, Cork LC, Morris JM, Winkelstein JA (1988) Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol 140:1939–1945PubMedGoogle Scholar
  110. Papamichail M, Gutierrez C, Embling P, Johnson P, Holborow EJ, Pepys MB (1975) Complement dependence of localisation of aggregated IgG in germinal centers. Scand J Immunol 4:343–347PubMedGoogle Scholar
  111. Pepys MB (1976) Role of complement in the induction of immunological responses. Transplant Rev 32:93–120PubMedGoogle Scholar
  112. Pirron U, Schlunck T, Prinz JC, Rieber EP (1990) IgE-dependent antigen focusing by human B lymphocytes is mediated by low-affinity receptor for IgE. Eur J Immunol 20:1547–1551PubMedGoogle Scholar
  113. Pollack W (1984) In haemolytic disease of the newborn (Garratty, G., ed). Am Assoc Blood Banks 53–66Google Scholar
  114. Powell R, Hutchings P, Cooke A, Lydyard PM (1982) Antibody mediated regulation of immune responses I. Enhancement of specific antibody responses through IgM antibodies. Immunol Lett 4:253–258PubMedGoogle Scholar
  115. Quintana IZ, Silveira AV, Möller G (1987) Regulation of the antibody response to sheep erythrocytes by monoclonal IgG antibodies. Eur J Immunol 17:1343–1349PubMedGoogle Scholar
  116. Roozendaal R, Carroll MC (2007) Complement receptors CD21 and CD35 in humoral immunity. Immunol Rev 219:157–166PubMedGoogle Scholar
  117. Rosenwasser LJ, Busse WW, Lizambri RG, Olejnik TA, Totoritis MC (2003) Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J Allergy Clin Immunol 112(3):563–570PubMedGoogle Scholar
  118. Rutemark C, Alicot E, Bergman A, Ma M, Getahun A, Ellmerich S et al (2011) Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc Natl Acad Sci USA 108(43):E934–E942PubMedGoogle Scholar
  119. Safford JJW, Tokuda S (1971) Antibody-mediated suppression of the immune response: effect on the development of immunologic memory. J Immunol 107:1213–1225PubMedGoogle Scholar
  120. Schrader JW (1973) Regulation of the immune response by IgM antibody: a paradoxical suppression of the in vitro primary immune response to sheep erythrocytes by IgM. Aust J Exp Biol Med Sci 51:333–346PubMedGoogle Scholar
  121. Shulman MJ, Collins C, Pennell N, Hozumi N (1987) Complement activation by IgM: evidence for the importance of the third constant domain of the μ heavy chain. Eur J Immunol 17:549–554PubMedGoogle Scholar
  122. Spiegelberg HL, Weigle WO (1965) The catabolism of homologous and heterologous 7s gamma globulin fragments. J Exp Med 121:323–338PubMedGoogle Scholar
  123. Squire CM, Studer EJ, Lees A, Finkelman FD, Conrad DH (1994) Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates. J Immunol 152(9):4388–4396PubMedGoogle Scholar
  124. Stoner RD, Terres G (1963) Enhanced antitoxin responses in irradiated mice elicited by complexes of tetanus toxoid and specific antibody. J Immunol 91:761–770PubMedGoogle Scholar
  125. Strannegård Ö, Belin L (1970) Suppression of reagin synthesis in rabbits by passively administered antibody. Immunology 20:775–785Google Scholar
  126. Strannegård Ö, Belin L (1971) Enhancement of reagin formation in rabbits by passively administered 19S antibody. Immunology 20:427–431PubMedGoogle Scholar
  127. Takizawa F, Adamczewski M, Kinet J-P (1992) Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as FcγRII and FcγRIII. J Exp Med 176:469–476PubMedGoogle Scholar
  128. Tao TW, Uhr JW (1966) Capacity of pepsin-digested antibody to inhibit antibody formation. Nature 212:208–209PubMedGoogle Scholar
  129. Terres G, Habicht GS, Stoner RD (1974) Carrier-specific enhancement of the immune response using antigen-antibody complexes. J Immunol 112:804–811PubMedGoogle Scholar
  130. Uhr JW, Möller G (1968) Regulatory effect of antibody on the immune response. Adv Immunol 8:81–127PubMedGoogle Scholar
  131. Urbaniak SJ, Greiss MA (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev 14(1):44–61PubMedGoogle Scholar
  132. van der Heijden FL, van Neerven RJJ, van Katwijk M, Bos JD, Kapsenberg ML (1993) Serum-­IgE-facilitated allergen presentation in atopic disease. J Immunol 150:1–8Google Scholar
  133. van Neerven RJJ, Wikborg T, Lund G, Jacobsen B, Brich-Nielsen Å, Arnved J et al (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163:2944–2952PubMedGoogle Scholar
  134. van Neerven RJJ, Arvidsson M, Ipsen H, Sparholt SH, Rak S, Würtzen PA (2004) A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-­immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 34:420–428PubMedGoogle Scholar
  135. von Behring E, Wernicke E (1892) Über Immunisierung und Heilung von Versuchstieren bei der Diphterie. Z Hyg Infektionskrankheit 12:10–44Google Scholar
  136. Walker JG, Siskind GW (1968) Studies on the control of antibody synthesis. Effect of antibody affinity upon its ability to suppress antibody formation. Immunology 14:21–28PubMedGoogle Scholar
  137. Wason WM (1973) Regulation of the immune response with antigen specific IgM antibody: a dual role. J Immunol 110:1245–1252PubMedGoogle Scholar
  138. Welliver RC, Wong DT, Middleton E Jr, Sun M, McCarthy N, Ogra PL (1982) Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J Pediatr 101(6):889–896PubMedGoogle Scholar
  139. Wernersson S, Karlsson M, Dahlström J, Mattsson R, Verbeek JS, Heyman B (1999) IgG-mediated enhancement of Ab responses is low in FcRγ chain deficient mice and increased in FcγRII deficient mice. J Immunol 163:618–622PubMedGoogle Scholar
  140. Westman S, Gustavsson S, Heyman B (1997) Early expansion of secondary B cells after primary immunization with antigen complexed with IgE. Scand J Immunol 46:10–15PubMedGoogle Scholar
  141. Whited-Collisson E, Andersson B, Lamon EW (1979) Modulation of hapten-specific responses with anticarrier antibody: I. differential effects of IgM and IgG anticarrier on primary direct and indirect hapten-specific plaque-forming cells. Proc Soc Exp Biol Med 162:194–198Google Scholar
  142. Whited Collisson E, Andersson B, Rönnholm M, Lamon E (1983) Potentiation of antibody responses by specific IgM: specificity and thymus dependency. Cell Immunol 79:44–55Google Scholar
  143. Whited Collisson E, Andersson B, Lamon EW (1984) Avidities of hapten-specific antibodies when the responses are modulated by anti-carrier antibodies. Immunology 53:443–449PubMedGoogle Scholar
  144. Wiersma EJ (1991) Effects of IgG antibodies and complement on the immune response. Thesis Uppsala University,p 26Google Scholar
  145. Wiersma EJ (1992) Enhancement of the antibody response to protein antigens by specific IgG under different experimental conditions. Scand J Immunol 36:193–200PubMedGoogle Scholar
  146. Wiersma EJ, Coulie PG, Heyman B (1989) Dual immunoregulatory effects of monoclonal IgG-­antibodies: suppression and enhancement of the antibody response. Scand J Immunol 29:439–448PubMedGoogle Scholar
  147. Wiersma EJ, Nose M, Heyman B (1990) Evidence of IgG-mediated enhancement of the antibody response in mice without classical pathway complement activation. Eur J Immunol 20:2585–2589PubMedGoogle Scholar
  148. Woodrow JC, Clarke CA, Donohow WT, Finn R, McConnell RB, Sheppard PM et al (1975) Mechanism of Rh prophylaxis: an experimental study on specificity of immunosuppression. Br Med J 2:57–59PubMedGoogle Scholar
  149. Youd ME, Ferguson AR, Corley RB (2002) Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur J Immunol 32:2328–2337PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Medical Biochemistry and MicrobiologyUppsala UniversityUppsalaSweden

Personalised recommendations